Intellia Therapeutics Inc buy Raymond James
Start price
10.11.23
/
50%
€22.91
Target price
10.11.24
€53.33
Performance (%)
-12.13%
Price
12:26
€20.13
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.13%. This prediction currently runs until 10.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -3.881% | -3.881% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by Raymond_James for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Raymond James from $78.00 to $57.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat